Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Oscier

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Blood|March 15, 1997
International scoring system for evaluating prognosis in myelodysplastic syndromesP Greenberg, C Cox, M M LeBeau, et al.
Genomics|February 13, 2001
Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14B Kapanadze, N Makeeva, M Corcoran, et al.
Blood|October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML GroupE Wattel, A Guerci, B Hecquet, et al.
Leukemia|October 22, 2015
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1M Larrayoz, S J Blakemore, R C Dobson, et al.
Genes, Chromosomes & Cancer|September 11, 2001
Identification of four new translocations involving FGFR1 in myeloid disordersJ Sohal, A Chase, S Mould, et al.
Leukemia|December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaE Matutes, D Oscier, C Montalban, et al.
Lancet (London, England)|July 31, 2007
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trialD Catovsky, S Richards, E Matutes, et al.
Oncogene|December 12, 1997
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemiaY Liu, M Corcoran, O Rasool, et al.
Leukemia|November 28, 2014
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotypeA Clipson, M Wang, L de Leval, et al.
Leukemia|April 6, 2013
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2J C Strefford, L-A Sutton, P Baliakas, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Blood|March 15, 1997
International scoring system for evaluating prognosis in myelodysplastic syndromesP Greenberg, C Cox, M M LeBeau, et al.
Genomics|February 13, 2001
Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14B Kapanadze, N Makeeva, M Corcoran, et al.
Blood|October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML GroupE Wattel, A Guerci, B Hecquet, et al.
Leukemia|October 22, 2015
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1M Larrayoz, S J Blakemore, R C Dobson, et al.
Genes, Chromosomes & Cancer|September 11, 2001
Identification of four new translocations involving FGFR1 in myeloid disordersJ Sohal, A Chase, S Mould, et al.
Leukemia|December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaE Matutes, D Oscier, C Montalban, et al.
Lancet (London, England)|July 31, 2007
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trialD Catovsky, S Richards, E Matutes, et al.
Oncogene|December 12, 1997
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemiaY Liu, M Corcoran, O Rasool, et al.
Leukemia|November 28, 2014
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotypeA Clipson, M Wang, L de Leval, et al.
Leukemia|April 6, 2013
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2J C Strefford, L-A Sutton, P Baliakas, et al.
Pageof 5